{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:11:57Z","timestamp":1791000717292,"version":"4.1.0"},"reference-count":89,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Toxins from toads have long been known to contain rich chemicals with great pharmaceutical potential. Recent studies have shown more than 100 such chemical components, including peptides, steroids, indole alkaloids, bufogargarizanines, organic acids, and others, in the parotoid and skins gland secretions from different species of toads. In traditional Chinese medicine (TCM), processed toad toxins have been used for treating various diseases for hundreds of years. Modern studies, including both experimental and clinical trials, have also revealed the molecular mechanisms that support the development of these components into medicines for the treatment of inflammatory diseases and cancers. More recently, there have been studies that demonstrated the therapeutic potential of toxins from other species of toads, such as Australian cane toads. Previous reviews mostly focused on the pharmaceutical effects of the whole extracts from parotoid glands or skins of toads. However, to fully understand the molecular basis of toad toxins in their use for therapy, a comprehensive understanding of the individual compound contained in toad toxins is necessary; thus, this paper seeks to review the recent studies of some typical compounds frequently identified in toad secretions.<\/jats:p>","DOI":"10.3390\/toxins10080336","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T11:23:06Z","timestamp":1534764186000},"page":"336","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["The Development of Toad Toxins as Potential Therapeutic Agents"],"prefix":"10.3390","volume":"10","author":[{"given":"Ji","family":"Qi","sequence":"first","affiliation":[{"name":"Menzies Health Institute Queensland and School of Medical Science, Griffith University, Gold Coast, QLD 4222, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Hasanat Md","family":"Zulfiker","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Marshall University, Huntington, WV 25701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[{"name":"Menzies Health Institute Queensland and School of Medical Science, Griffith University, Gold Coast, QLD 4222, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Good","sequence":"additional","affiliation":[{"name":"Menzies Health Institute Queensland and School of Medical Science, Griffith University, Gold Coast, QLD 4222, Australia"},{"name":"School of Physiotherapy, Australian Catholic University, Banyo, QLD 4014, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Q.","family":"Wei","sequence":"additional","affiliation":[{"name":"Menzies Health Institute Queensland and School of Medical Science, Griffith University, Gold Coast, QLD 4222, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Angel of human health: Current research updates in toad medicine","volume":"7","author":"Yang","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jep.2010.07.017","article-title":"Comparison of toad venoms from different Bufo species by HPLC LC-DAD-MS\/MS","volume":"131","author":"Gao","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jep.2016.03.062","article-title":"Chemical profiling and cytotoxicity assay of bufadienolides in toad venom and toad skin","volume":"187","author":"Meng","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Qi, J., Tan, C., Hashimi, S.M., Zulfiker, A.H.M., Good, D., and Wei, M.Q. (2014). Toad glandular secretions and skin extractions as anti-inflammatory and anticancer agents. Evid.-Based Complement. Altern. Med., 2014.","DOI":"10.1155\/2014\/312684"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1002\/cncr.24602","article-title":"Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer","volume":"115","author":"Meng","year":"2009","journal-title":"Cancer"},{"key":"ref_6","first-page":"006","article-title":"Phase I study of huachansu in hepatocellular carcinoma, non-small cell lung cancer, and pancreatic cancer: A preliminary report","volume":"5","author":"Meng","year":"2001","journal-title":"Chin. Oncol."},{"key":"ref_7","first-page":"2141","article-title":"Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells","volume":"31","author":"Wang","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3892\/ijo.2015.3044","article-title":"Huachansu mediates cell death in non-Hodgkin\u2019s lymphoma by induction of caspase-3 and inhibition of MAP kinase","volume":"47","author":"Efuet","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1073\/pnas.1422997112","article-title":"Structures and characterization of digoxin-and bufalin-bound Na+, K+-ATPase compared with the ouabain-bound complex","volume":"112","author":"Laursen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nrd2682","article-title":"Novel therapeutic applications of cardiac glycosides","volume":"7","author":"Prassas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0002-9149(92)91259-7","article-title":"Recognition and management of digitalis toxicity","volume":"69","author":"Kelly","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"ref_12","first-page":"20","article-title":"Bufadienolides and their medicinal utility: A review","volume":"5","author":"Kamboj","year":"2013","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Baldo, E.C.F., Anjolette, F.A.P., Arantes, E.C., and Baldo, M.A. (2015). Toad Poison and Drug Discovery. Toxicon, 1\u201322.","DOI":"10.1007\/978-94-007-6726-3_16-1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S0956536100002297","article-title":"Identity of a New World psychoactive toad","volume":"3","author":"Davis","year":"1992","journal-title":"Anc. Mesoam."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-8741(94)90051-5","article-title":"Bufo alvarius: A potent hallucinogen of animal origin","volume":"41","author":"Weil","year":"1994","journal-title":"J. Ethnopharmacol."},{"key":"ref_16","first-page":"1","article-title":"Bufotenine-A Hallucinogen in Ancient Snuff Powders of South America and a Drug of Abuse on the Streets of New York City","volume":"6","author":"Chamakura","year":"1994","journal-title":"Forensic Sci. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1442-9993.2007.01664.x","article-title":"Rapid expansion of the cane toad (Bufo marinus) invasion front in tropical Australia","volume":"32","author":"Phillips","year":"2007","journal-title":"Aust. Ecol."},{"key":"ref_18","first-page":"1","article-title":"Novel drugs from toad skins","volume":"17","author":"Leitch","year":"2000","journal-title":"RIDC Publ. Aust."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/jcb.25577","article-title":"Aqueous and Ethanol Extracts of Australian Cane Toad Skins Suppress Pro-Inflammatory Cytokine Secretion in U937 Cells via NF-\u03baB Signaling Pathway","volume":"117","author":"Zulfiker","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/jcb.25627","article-title":"Cane Toad Skin Extract\u2014Induced Upregulation and Increased Interaction of Serotonin 2A and D2 Receptors via Gq\/11 Signaling Pathway in CLU213 Cells","volume":"118","author":"Zulfiker","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/cbdv.201000283","article-title":"Chemical constituents and bioactivities of the skin of Bufo bufo gargarizans Cantor","volume":"8","author":"Wang","year":"2011","journal-title":"Chem. Biodivers."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpba.2016.06.031","article-title":"Multi-constituent identification in Australian cane toad skin extracts using high-performance liquid chromatography high-resolution tandem mass spectrometry","volume":"129","author":"Zulfiker","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.toxicon.2005.01.017","article-title":"Antimicrobial activity of the bufadienolides marinobufagin and telocinobufagin isolated as major components from skin secretion of the toad Bufo rubescens","volume":"45","author":"Schwartz","year":"2005","journal-title":"Toxicon"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.toxicon.2010.03.021","article-title":"Cytotoxic profile of natural and some modified bufadienolides from toad Rhinella schneideri parotoid gland secretion","volume":"56","author":"Resck","year":"2010","journal-title":"Toxicon"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1871524915666150724100245","article-title":"Indolealkylamines from toad vertebrates and sea invertebrates-their identification and potential activities on the central nervous system","volume":"16","author":"Zulfiker","year":"2016","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"ref_26","first-page":"17","article-title":"Toad skin-secretions: Potent source of pharmacologically and therapeutically significant compounds","volume":"5","author":"Garg","year":"2008","journal-title":"Int. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.15806\/j.issn.2311-8571.2014.0024","article-title":"Advancement in research of anti-cancer effects of toad venom (ChanSu) and perspectives","volume":"1","author":"Liu","year":"2015","journal-title":"World J. Tradit. Chin. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1590\/S0100-40422013000500013","article-title":"Preparative separation and purification of bufadienolides from ChanSu by high-speed counter-current chromatography combined with preparative HPLC","volume":"36","author":"Li","year":"2013","journal-title":"Qu\u00edmica Nova"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jchromb.2006.04.042","article-title":"Simultaneous determination of cytotoxic bufadienolides in the Chinese medicine ChanSu by high-performance liquid chromatography coupled with photodiode array and mass spectrometry detections","volume":"838","author":"Ye","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"ref_30","first-page":"005","article-title":"Isolation and identification of the indolealkylamines from the traditional Chinese medicine Toad Venom","volume":"4","author":"Zhang","year":"2006","journal-title":"J. Shenyang Pharm. Univ."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/jssc.201200036","article-title":"Simultaneous determination of eight bufadienolides in cinobufacini injection by HPLC coupled with triple quadrupole mass spectrometry","volume":"35","author":"Wu","year":"2012","journal-title":"J. Sep. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/0973-1296.137358","article-title":"Comparison of toad skins Bufo bufo gargarizans Cantor from different regions for their active constituents content and cytotoxic activity on lung carcinoma cell lines","volume":"10","author":"Liu","year":"2014","journal-title":"Pharmacogn. Mag."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/bjc.2012.283","article-title":"Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: A randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas","volume":"107","author":"Meng","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1086\/655116","article-title":"The ecological impact of invasive cane toads (Bufo marinus) in Australia","volume":"85","author":"Shine","year":"2010","journal-title":"Q. Rev. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/bmc.2858","article-title":"Rapid identification of primary constituents in parotoid gland secretions of the Australian cane toad using HPLC\/MS-Q-TOF","volume":"27","author":"Jing","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1096-4959(03)00022-8","article-title":"Composition of indolealkylamines of Bufo rubescens cutaneous secretions compared to six other Brazilian bufonids with phylogenetic implications","volume":"134","author":"Maciel","year":"2003","journal-title":"Comp. Biochem. Physiol. Part B Biochem. Mol. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1520\/JFS14052J","article-title":"GC\/MS comparison of the West Indian aphrodisiac \u201cLove Stone\u201d to the Chinese medication \u201cchan su\u201d: Bufotenine and related bufadienolides","volume":"41","author":"Barry","year":"1996","journal-title":"J. Forensic. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/np400034d","article-title":"Structure\u2014Activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and human cancer cells","volume":"76","author":"Moreno","year":"2013","journal-title":"J. Natl. Prod."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s10495-011-0573-5","article-title":"Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3\/Mcl-1 pathway","volume":"16","author":"Dong","year":"2011","journal-title":"Apoptosis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1349-7006.2008.00966.x","article-title":"Apoptotic signaling in bufalin-and cinobufagin-treated androgen-dependent and-independent human prostate cancer cells","volume":"99","author":"Yu","year":"2008","journal-title":"Cancer Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3892\/or.2016.4946","article-title":"Effects of active bufadienolide compounds on human cancer cells and CD4+ CD25+ Foxp3+ regulatory T cells in mitogen-activated human peripheral blood mononuclear cells","volume":"36","author":"Yuan","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.7314\/APJCP.2012.13.11.5339","article-title":"Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: New hope for cancer patients","volume":"13","author":"Yin","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Karin, M. (2009). NF-\u03baB as a critical link between inflammation and cancer. Cold Spring Harbor Perspect. Biol.","DOI":"10.1101\/cshperspect.a000141"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000450754","article-title":"Bufalin inhibits the inflammatory effects in asthmatic mice through the suppression of nuclear factor-kappa B activity","volume":"99","author":"Zhakeer","year":"2017","journal-title":"Pharmacology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"171839","DOI":"10.1155\/2014\/171839","article-title":"Anti-Inflammatory and Antinociceptive Activities of Bufalin in Rodents","volume":"2014","author":"Wen","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/tox.21896","article-title":"Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2\/-9-signaling pathways","volume":"30","author":"Chen","year":"2015","journal-title":"Environ. Toxicol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1142\/S0192415X15500718","article-title":"Bufalin inhibits NCI-H460 human lung cancer cell metastasis in vitro by inhibiting MAPKs, MMPs, and NF-\u03baB pathways","volume":"43","author":"Wu","year":"2015","journal-title":"Am J. Chin. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7314\/APJCP.2012.13.1.399","article-title":"Bufalin, a traditional oriental medicine, induces apoptosis in human cancer cells","volume":"13","author":"Takai","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.v13.i24.3374","article-title":"Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice","volume":"13","author":"Han","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1479-5876-12-57","article-title":"Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice","volume":"12","author":"Zhang","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wang, J., Chen, C., Wang, S., Zhang, Y., Yin, P., Gao, Z., Xu, J., Feng, D., Zuo, Q., and Zhao, R. (2015). Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN\/AKT Pathways. Gastroenterol. Res. Pract., 2015.","DOI":"10.1155\/2015\/457193"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/tox.22325","article-title":"Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo","volume":"32","author":"Wu","year":"2017","journal-title":"Environ. Toxicol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Li, C., Hashimi, S.M., Cao, S., Mellick, A.S., Duan, W., Good, D., and Wei, M.Q. (2013). The mechanisms of chansu in inducing efficient apoptosis in colon cancer cells. Evid.-Based Complement. Altern. Med., 2013.","DOI":"10.1155\/2013\/849054"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Li, C., Hashimi, S.M., Cao, S., Qi, J., Good, D., Duan, W., and Wei, M.Q. (2015). Chansu inhibits the expression of cortactin in colon cancer cell lines in vitro and in vivo. BMC Complement. Altern. Med., 15.","DOI":"10.1186\/s12906-015-0723-3"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2016.11.016","article-title":"Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling","volume":"794","author":"Cao","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2147\/OTT.S104767","article-title":"Arenobufagin activates p53 to trigger esophageal squamous cell carcinoma cell apoptosis in vitro and in vivo","volume":"10","author":"Lv","year":"2017","journal-title":"OncoTargets Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/carcin\/bgt060","article-title":"Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K\/Akt\/mTOR pathway","volume":"34","author":"Zhang","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.phrs.2017.07.009","article-title":"Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating \u03b2-catenin","volume":"123","author":"Chen","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.bcp.2012.01.023","article-title":"Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway","volume":"83","author":"Li","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.18632\/oncotarget.6514","article-title":"Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15725","DOI":"10.18632\/oncotarget.7398","article-title":"Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1476-4598-13-203","article-title":"Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKK\u03b2\/NF-\u03baB signaling pathway in lung cancer cells","volume":"13","author":"Yu","year":"2014","journal-title":"Mol. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1472-8206.2009.00696.x","article-title":"The effects of telocinobufagin isolated from Chan Su on the activation and cytokine secretion of immunocytes in vitro","volume":"23","author":"Cao","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_64","first-page":"19","article-title":"Poisons of toads","volume":"12","author":"Sementsov","year":"1939","journal-title":"Farm. Zh. (Kharkov)"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/138920010794233495","article-title":"Psychedelic 5-methoxy-N,N-dimethyltryptamine: Metabolism, pharmacokinetics, drug interactions, and pharmacological actions","volume":"11","author":"Shen","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-3565(24)36476-6","article-title":"High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: Evidence in favor of a modified ternary complex model","volume":"280","author":"Roth","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0378-4347(00)81837-X","article-title":"Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine","volume":"162","author":"Raisanen","year":"1979","journal-title":"J. Chromatogr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1097\/00001756-199511270-00024","article-title":"Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders","volume":"6","author":"Takeda","year":"1995","journal-title":"Neuroreport"},{"key":"ref_69","first-page":"117","article-title":"Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia","volume":"31","author":"Emanuele","year":"2010","journal-title":"Neuro Endocrinol. Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1134\/S1607672917010136","article-title":"N-methyl serotonin analogues from the Bufo bufo toad venom interact efficiently with the alpha7 nicotinic acetylcholine receptors","volume":"472","author":"Kryukova","year":"2017","journal-title":"Dokl. Biochem. Biophys."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-2952(70)90189-9","article-title":"Biogenic amines and active polypeptides in the skin of Leptodactylus vilarsi melin","volume":"19","author":"Erspamer","year":"1970","journal-title":"Biochem. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-3565(25)26403-5","article-title":"Action of indole alkylamines and amidines on the inferior mesenteric ganglion of the cat","volume":"138","author":"Gyermek","year":"1962","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_73","first-page":"858","article-title":"Isolation and structure identification of chemical constituents from the skin of Bufo bufo gargarizans","volume":"42","author":"Dai","year":"2007","journal-title":"Yao Xue Xue Bao"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/ja00058a003","article-title":"Novel cytotoxic topoisomerase II inhibiting pyrroloiminoquinones from Fijian sponges of the genus Zyzzya","volume":"115","author":"Radisky","year":"1993","journal-title":"J. Am. Chem. Soc."},{"key":"ref_75","first-page":"333","article-title":"Makaluvamines, marine natural-products, are active anticancer agents and DNA topo-ii inhibitors","volume":"8","author":"Barrows","year":"1993","journal-title":"Anti-Cancer Drug Des."},{"key":"ref_76","first-page":"55","article-title":"Dehydrobufotenine dry powder inhaler (DPI), its preparation method and application in preparation of antitumor drug for treating lung tumor","volume":"8","author":"Zhang","year":"2012","journal-title":"Am. Chem. Soc."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jep.2011.12.018","article-title":"Bufothionine, a possible effective component in cinobufocini injection for hepatocellular carcinoma","volume":"141","author":"Xie","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"ref_78","unstructured":"Gao, B., and Luo, C. (2012). Method for Extracting Bufothionine from Skin of Bufo Bufo Gargarizans Cantor, Anhui Jinchan Biochemical Co., Ltd."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Dai, Y.H., Shen, B., Xia, M.Y., Wang, A.D., Chen, Y.L., Liu, D.C., and Wang, D. (2016). A New Indole Alkaloid from the Toad Venom of Bufo bufo gargarizans. Molecules, 21.","DOI":"10.3390\/molecules21030349"},{"key":"ref_80","unstructured":"Zhou, Y., and Liu, J. (New Formulations of Alkaloid from Toad Skin for Cancer Therapy, 2017). New Formulations of Alkaloid from Toad Skin for Cancer Therapy."},{"key":"ref_81","unstructured":"Chen, Y., Zhang, Z., Jia, X., Zhou, L., and Wu, Q. (Bufothionine Powder for Inhalation and its Preparation and Application for Treating Pulmonary Neoplasm, 2011). Bufothionine Powder for Inhalation and its Preparation and Application for Treating Pulmonary Neoplasm."},{"key":"ref_82","first-page":"12","article-title":"Psychoactive natural products: Overview of recent developments","volume":"50","year":"2014","journal-title":"Annali dell\u2019Istituto Superiore Sanita"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3565(25)26625-3","article-title":"Anti-inflammatory and antipyretic activities of indo-methacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid","volume":"141","author":"Winter","year":"1963","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s11274-008-9933-x","article-title":"Actinomycetes isolated from medicinal plant rhizosphere soils: Diversity and screening of antifungal compounds, indole-3-acetic acid and siderophore production","volume":"25","author":"Khamna","year":"2009","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI104482","article-title":"Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous blood","volume":"41","author":"Seltzer","year":"1962","journal-title":"J. Clin. Investig."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0006-2952(00)00498-6","article-title":"Oxidative activation of indole-3-acetic acids to cytotoxic species\u2014A potential new role for plant auxins in cancer therapy","volume":"61","author":"Folkes","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1136\/heart.89.4.e14","article-title":"Toad venom poisoning: Resemblance to digoxin toxicity and therapeutic implications","volume":"89","author":"Gowda","year":"2003","journal-title":"Heart"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1039\/c0np00032a","article-title":"Bufadienolides and their antitumor activity","volume":"28","author":"Gao","year":"2011","journal-title":"Nat. Prod. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s12272-011-0910-9","article-title":"Improved antitumor efficacy and reduced toxicity of liposomes containing bufadienolides","volume":"34","author":"Hu","year":"2011","journal-title":"Arch. Pharm. Res."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/10\/8\/336\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:19:48Z","timestamp":1760195988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/10\/8\/336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":89,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["toxins10080336"],"URL":"https:\/\/doi.org\/10.3390\/toxins10080336","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]}}}